seekingalpha.com
Vivesto AB (OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise Transcript
Vivesto AB (OTC:OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise November 24, 2025 9:00 AM EST Company Participants Peter Zonabend Erik Kinnmann - Chief Executive Officer Henrik Rönnberg - Chief Medical Officer of Animal Health Teresa Zafra - Chief Scientific Officer & Head of Preclinical Development & Clinical Operations Johanna Rostin - Chief Regulatory Officer Conference Call Participants Mikael Magnusson James Perry Bjørn Tore Gjertsen Nina Herne Presentation Mikael Magnusson The clock strikes 3:00 p.m., and we welcome viewers here to Vivesto's business update.